V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10169424 | 10068389 | 1.74 | 0 | Palliative (P) | 2018-07-25 | 2018-07-25 | Avelumab | 02 | N | VENETOCLAX | 100660211 |
| 10170001 | 10068390 | 1.75 | 45.8 | Palliative (P) | 2020-10-08 | 2020-12-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101077469 |
| 10170837 | 10068391 | 1.82 | 76.3 | null | 2019-11-18 | 2019-11-18 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + OXALIPLATIN | 101050963 |
| 10173655 | 10068393 | 1.62 | 59 | null | 2021-03-12 | 2021-03-12 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101284343 |
| 10176151 | 10068394 | 1.88 | 47.6 | null | 2020-12-15 | 2020-12-15 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101107491 |
| 10178801 | 10068395 | 1.58 | 64.7 | null | 2022-04-26 | 2022-05-15 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100545570 |
| 10183708 | 10068396 | 1.72 | 74.4 | null | 2017-05-20 | 2017-06-09 | GemCarbo Days 1+8 | 2 | null | CARBOPLATIN + GEMCITABINE | 100426929 |
| 10185620 | 10068398 | 1.71 | 87.6 | Palliative (P) | 2022-01-03 | 2022-02-01 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100948685 |
| 10186199 | 10068399 | 1.83 | 58.7 | null | 2016-08-22 | 2019-07-15 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 101743237 |
| 10191357 | 10068400 | null | 100 | null | 2020-03-17 | 2020-03-17 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100572795 |
| 10192863 | 10068401 | 1.64 | 81.3 | null | 2017-09-14 | 2018-08-17 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100364497 |
| 10194450 | 10068402 | 1.58 | 81.8 | Palliative (P) | 2017-04-20 | 2018-03-31 | NIVOLUMAB | 02 | Y | NIVOLUMAB | 100889408 |
| 10195063 | 10068403 | 1.65 | 71.7 | null | 2020-10-06 | 2020-11-18 | BENDAMUSTINE + RITUXIMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 101337089 |
| 10198429 | 10068404 | 1.81 | 56.2 | Palliative (P) | 2022-02-06 | 2022-02-08 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 100216403 |
| 10201751 | 10068405 | 1.66 | 81 | Palliative (P) | 2015-02-11 | 2021-05-26 | Venetoclax | 02 | N | VENETOCLAX | 100266172 |
| 10201773 | 10068406 | 1.7 | 82 | null | 2022-02-01 | 2022-02-01 | Bendamustine+Rituximab(Sub Courses) | 02 | null | BENDAMUSTINE + RITUXIMAB | 101630524 |
| 10203444 | 10068407 | 1.85 | 71.8 | Palliative (P) | null | 2021-03-05 | Venetoclax | 02 | null | VENETOCLAX | 101769905 |
| 10205839 | 10068410 | 1.64 | 91.3 | Palliative (P) | 2021-02-11 | 2021-02-13 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 101001615 |
| 10206060 | 10068411 | 1.7 | 71.8 | null | 2019-03-24 | 2020-02-15 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 100933397 |
| 10206452 | 10068412 | 1.7 | 94 | null | 2020-02-20 | 2020-07-07 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100500639 |
| 10206789 | 10068413 | 0 | 63.8 | null | 2016-06-07 | 2016-06-07 | Avelumab | 02 | null | TRASTUZUMAB | 101527823 |
| 10207631 | 10068415 | 0 | 59 | Palliative (P) | 2020-06-01 | 2020-06-07 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101054565 |
| 10207971 | 10068416 | 1.77 | 79.5 | Palliative (P) | 2021-10-24 | 2021-10-31 | Avelumab | 02 | N | AVELUMAB | 100573520 |
| 10208401 | 10068418 | 1.8 | 71 | null | null | 2019-09-03 | FLUOROURACIL + OXALIPLATIN | 01 | null | FLUOROURACIL + OXALIPLATIN | 101611354 |
| 10208849 | 10068420 | null | 92.4 | null | 2020-02-24 | 2020-04-17 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100114234 |
| 10209468 | 10068421 | 1.79 | 38.6 | null | 2016-06-18 | 2017-08-28 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 100484995 |
| 10209795 | 10068422 | 1.82 | 68.7 | Palliative (P) | 2021-02-17 | 2021-07-03 | Avelumab | 02 | N | TRASTUZUMAB | 100460136 |
| 10209860 | 10068423 | 1.81 | 151.2 | null | 2019-06-25 | 2019-11-01 | Avelumab | 99 | N | FLUOROURACIL + IRINOTECAN | 101658124 |
| 10209910 | 10068424 | 1.61 | 67.2 | Palliative (P) | 2022-02-23 | 2022-03-26 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 100011953 |
| 10209994 | 10068425 | 1.86 | 70 | null | 2019-07-25 | 2019-09-03 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 100980107 |
| 10210142 | 10068426 | 1.53 | 45.8 | Palliative (P) | 2020-03-30 | 2020-03-30 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100073099 |
| 10210868 | 10068427 | 1.51 | 79.4 | null | 2021-04-19 | 2021-06-03 | Avelumab | 02 | null | NIVOLUMAB | 100490163 |
| 10213958 | 10068430 | 1.68 | 63.8 | Adjuvant (A) | 2020-05-03 | 2020-07-27 | Venetoclax | 02 | N | VENETOCLAX | 100556054 |
| 10214003 | 10068431 | 1.73 | 102 | Adjuvant (A) | 2020-08-07 | 2020-08-07 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 101153356 |
| 10214479 | 10068433 | 1.62 | 44.6 | Palliative (P) | 2020-12-14 | 2022-05-10 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100138752 |
| 10217275 | 10068435 | 1.66 | 64.1 | null | 2017-10-20 | 2017-10-20 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100525459 |
| 10217766 | 10068436 | 1.61 | 102.2 | Curative (C) | 2022-05-12 | 2022-05-12 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101733308 |
| 10217817 | 10068437 | 1.76 | null | null | 2019-10-10 | 2020-02-15 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101679940 |
| 10218005 | 10068438 | 1.83 | 61.2 | null | 2017-07-20 | 2017-08-16 | Avelumab | 02 | null | AVELUMAB | 101762117 |
| 10221607 | 10068440 | 1.77 | 61.8 | Palliative (P) | 2019-03-10 | 2019-04-03 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100583888 |
| 10221782 | 10068441 | 1.58 | 68.7 | Palliative (P) | 2021-06-01 | 2021-08-28 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101823022 |
| 10223151 | 10068442 | 1.62 | 56 | null | 2021-04-09 | 2021-04-21 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101642991 |
| 10223264 | 10068443 | 0 | 86.8 | null | 2020-01-07 | 2020-04-03 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100082690 |
| 10224732 | 10068445 | 1.63 | 72.6 | Palliative (P) | 2019-01-12 | 2019-02-03 | Trastuzumab | 02 | N | TRASTUZUMAB | 101505407 |
| 10224890 | 10068446 | 1.63 | 56.2 | Adjuvant (A) | 2021-09-12 | 2021-10-13 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 101393141 |
| 10226421 | 10068449 | 1.69 | 64.4 | null | null | 2017-06-27 | RUXOLITINIB | N | null | RUXOLITINIB | 100456390 |
| 10226635 | 10068450 | 1.73 | 56 | null | 2021-08-13 | 2021-09-02 | Oxaliplatin + Modified de Gramont | 02 | null | FLUOROURACIL + OXALIPLATIN | 101668852 |
| 10226763 | 10068451 | 1.6 | 64.6 | Palliative (P) | 2021-11-19 | 2022-01-21 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101141825 |
| 10226863 | 10068452 | 1.65 | 58.2 | null | 2020-04-14 | 2020-04-16 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101573223 |
| 10230784 | 10068455 | 1.62 | 0 | 03 | 2021-02-20 | 2021-04-19 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 101146406 |